News Articles Tagged: FDA Warnings

The Regulatory Crossroads of 5-Alpha-Hydroxy-Laxogenin: What Manufacturers Need to Know

NINGBO INNO PHARMCHEM CO.,LTD. discusses the critical regulatory challenges facing 5-Alpha-Hydroxy-Laxogenin and its implications for supplement manufacturers.

The Legal Landscape of Melanotan II: Why It's Not Approved for Tanning

Examines the regulatory status of Melanotan II, explaining why it remains an unapproved substance for cosmetic tanning and the implications for consumers.

Tianeptine's Evolving Regulatory Status and the Impact of Unregulated Market Availability

Analyze the complex regulatory landscape of Tianeptine, from its approved status in some countries to its unregulated market presence and bans in others, highlighting the challenges for public health.